FDA Approved: ADAPALENE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for adapalene from Actavis Pharma, Inc., under ANDA 201000. The action indicates regulatory approval of changes subm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Adapalene (Adapalene)

Snippet

SUPPL AP for ADAPALENE (ADAPALENE)